InMed Pharmaceuticals, Inc. (INM)
1.585
+0.08
(+4.97%)
USD |
NASDAQ |
Jun 11, 16:00
1.585
0.00 (0.00%)
After-Hours: 19:31
InMed Pharmaceuticals Enterprise Value : 0.2238M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 0.2238M |
| June 09, 2026 | 0.2901M |
| June 08, 2026 | 0.3232M |
| June 05, 2026 | 0.4558M |
| June 04, 2026 | 0.3895M |
| June 03, 2026 | 0.4889M |
| June 02, 2026 | 0.2569M |
| June 01, 2026 | 0.3895M |
| May 29, 2026 | 0.4226M |
| May 28, 2026 | 0.7872M |
| May 27, 2026 | 0.7209M |
| May 26, 2026 | 0.9198M |
| May 22, 2026 | 0.9198M |
| May 21, 2026 | 0.9529M |
| May 20, 2026 | 0.5552M |
| May 19, 2026 | 0.5221M |
| May 18, 2026 | -2.525M |
| May 15, 2026 | -2.659M |
| May 14, 2026 | -2.626M |
| May 13, 2026 | -2.679M |
| May 12, 2026 | -2.610M |
| May 11, 2026 | -2.722M |
| May 08, 2026 | -2.626M |
| May 07, 2026 | -2.473M |
| May 06, 2026 | -2.373M |
| Date | Value |
|---|---|
| May 05, 2026 | -2.328M |
| May 04, 2026 | -2.301M |
| May 01, 2026 | -2.413M |
| April 30, 2026 | -2.394M |
| April 29, 2026 | -2.457M |
| April 28, 2026 | -2.457M |
| April 27, 2026 | -2.353M |
| April 24, 2026 | -2.224M |
| April 23, 2026 | -2.255M |
| April 22, 2026 | -2.205M |
| April 21, 2026 | -2.39M |
| April 20, 2026 | -2.384M |
| April 17, 2026 | -2.428M |
| April 16, 2026 | -2.461M |
| April 15, 2026 | -2.420M |
| April 14, 2026 | -2.412M |
| April 13, 2026 | -2.419M |
| April 10, 2026 | -2.409M |
| April 09, 2026 | -2.647M |
| April 08, 2026 | -2.637M |
| April 07, 2026 | -2.526M |
| April 06, 2026 | -2.478M |
| April 02, 2026 | -2.534M |
| April 01, 2026 | -2.559M |
| March 31, 2026 | -2.643M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| NervGen Pharma Corp. | 128.25M |
| Milestone Pharmaceuticals, Inc. | 96.82M |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | -9.859M |
| Pharmagreen Biotech, Inc. | 0.7227M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.792M |
| Total Expenses (Quarterly) | 2.792M |
| EPS Diluted (Quarterly) | -0.7327 |
| Earnings Yield | -162.5% |
| Normalized Earnings Yield | -162.49 |